<DOC>
	<DOCNO>NCT02539615</DOCNO>
	<brief_summary>The purpose study measure performance ForeCYTE Breast Aspirator collection process Nipple Aspirate Fluid ( NAF ) specimens cytology . Including collect , process shipping sample , train staff , processing sample , sample interpretation accurate timely report manner resemble routine clinical use . The study include subset patient know carrier BRCA germline mutation . NAF subset submit molecular test addition cytology .</brief_summary>
	<brief_title>A Trial ForeCYTE Breast Aspirator Cytological Testing Nipple Aspirate Fluid Women 30-55 Years Old</brief_title>
	<detailed_description />
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>1 . Healthy , female , age 3055 year , bilateral specimen obtain . The following additional consideration apply : Women prior mastectomy/lumpectomy may consider NAFcollection contralateral ( nonoperated ) breast : Stage I Stage II time surgery ; Have complete hormonal therapy , chemotherapy , target therapy least one year prior inclusion ; Are consider diseasefree ( NED No Evidence Disease ) time study entry ; Women age 30 may enrol within 10 year age diagnosis breast cancer firstdegree relative . No subject age 21 may enrol . 2 . Any woman NAFcytology test consider beneficial physician . This include , limited woman first and/or second degree relative breast ovarian cancer . Known presence BRCA1 BRCA2 germline mutation allow require . If know , mutation note Case Report Form . The protocol provide test woman without know germline mutation . 3 . Nonlactating nonpregnant . 4 . Good general health determine medical history , breast disease/cancer history , clinical breast exam . 5 . Willing give inform consent follow study procedure direct . Exclusion Criteria 1 . Medical condition/psychiatric condition make subject poor candidate study , determine Principal Investigator . 2 . Pregnancy suspicion pregnancy . 3 . Open cutaneous wound atopic dermatitis area nippleareolar complex . 4 . No inverted nipple breast unfit fluid collection , significant prior surgery area nippleareolar complex . 5 . Participation investigational drug device study le 30 day prior enrollment study . 6 . Pregnancy , childbirth , lactation le 90 day prior enrollment study . 7 . Acute illness , include take antibiotic , analgesic , antipyretic and/or cold medication less 7 day prior enrollment study .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>